Exhibit 107

Calculation of Filing Fee Table

FORM S-8

(Form Type)

Atara Biotherapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Newly Registered Securities

 

               
Security Type  

Security

Class

Title

   Fee
Calculation
Rule		   Amount
Registered (1)		   Proposed
Maximum
Offering
Price Per
Unit		   Maximum
Aggregate
Offering
Price		  

Fee

Rate

   Amount of
Registration
Fee(2)
               
Equity(3)  

Common Stock, $0.0001

par value per share

   Rule 457(c) and Rule 457(h)   6,900,000   $0.58   $4,002,000   0.00014760   $590.70
         
Total Offering Amounts         $590.70
         
Total Fee Offsets         —
         
Net Fee Due               $590.70

 

(1)

Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement shall also cover any additional shares of Registrant’s common stock that become issuable under the plans set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Registrant’s common stock, as applicable.

(2)

Estimated in accordance with Rules 457(c) and (h) solely for the purpose of calculating the registration fee on the basis of $0.58 per share, the average of the high and low prices of the Registrant’s common stock on June 4, 2024 as reported on the Nasdaq Global Select Market.

(3)

Represents shares of common stock that are available for issuance under the Registrant’s 2024 Equity Incentive Plan.